How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines
A case of Ghana
Bibliographic Data
| ID | 22081007 |
|---|---|
| Authors | Augustina Koduah (0000-0001-9915-5333, University of Ghana, corresponding author) |
| Year | 2023 |
| Volume | 11 |
| Pages | 1163342-1163342 |
| Publication date | 2023-07-07 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2023.1163342 |
| PMID | 37483923 |
| OpenAlex | W4383553894 |
| Language | EN |
| Citations received | 1 |
| References cited | 25 |
Background: Examining how and why a country prioritizes and implements pharmaceutical reforms tends to show complex processes and myriad efforts made toward improving access to medicines. This study examines factors that enabled the prioritization and implementation of selected pharmaceutical reform items and how these factors contributed to improving equitable access to medicines and universal health coverage in Ghana. Methods: An analytical framework was developed to identify variables to explore in answering the study questions and frame the analysis and presentation of findings. Documents analyzed included the National Medicines Policies, Health Sector Program of Work, and other health policies. Quantitative data were sourced from databases maintained by World Health Organization and the Institute for Health Metrics and Evaluation. Results: The three main factors, evidence, financial and technical support, and alignment to national and global policies, influenced the prioritization and implementation of access to medicines reforms. The reforms targeted rational selection and use of medicines, medicine pricing, sustainable medicine financing, and regulatory and supply chain systems. Although there were limited quantitative data to quantify access to medicine policies" impact on universal health coverage, it can be reasonably assumed that, in Ghana, access to medicine policies has contributed to financial protection and improved access to quality health services. Conclusion: Access to medicine policies targeted at promoting rational medicine selection and use, regulating medicine pricing and improving sustainable financing for medicines as well as the regulatory and supply chain systems arguably contributed to the attainment of UHC and must be sustained. Therefore, data collection and reporting indicators for access to medicines must be prioritized
Access to medicines · Business · Developing country · Economic growth · Economics · Essential medicines · Health care · Pharmaceutical policy · Public economics · Supply chain · Universal design · Computer Science · Healthcare Systems and Reforms · Pharmaceutical Economics and Policy · Pharmaceutical Quality and Counterfeiting · Health Policy · Marketing
Essential medicines for universal health coverage
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019
How and why do countries make Universal Health Care policies? Interplay of country and global factors
Universal access to essential medicines as part of the right to health
Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list
Transnational policy transfer
Public social policy development and implementation
Inappropriate use of medicines and associated factors in Brazil
Access to medicines from a health system perspective
How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan
Essential medicine shortages, procurement process and supplier response
The one with the purse makes policy
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |